Company filings profile · CIK 0000908259
Oncotelic Therapeutics, Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Oncotelic Therapeutics, Inc. (OTLC): 6 filings in the last 90 days vs 13 in the prior 90 (filing-velocity cooling ↓ · 0.46×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 14, 2026. Source-linked, daily-refreshed.
Material 8-K events — Oncotelic Therapeutics, Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 13, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Aug 4, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jul 14, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Jul 14, 2026 | Unregistered Sale of Securities; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Jun 29, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| May 5, 2026 | Entry into a Material Agreement; Completion of Acquisition/Disposition; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Apr 16, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Apr 2, 2026 | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 30, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Mar 30, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Jan 29, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jan 26, 2026 | Entry into a Material Agreement; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Jan 7, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jan 6, 2026 | Entry into a Material Agreement; Material Direct Financial Obligation; Financial Statements and Exhibits | ↗ |
| Jan 6, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
Watch Oncotelic Therapeutics, Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 13, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Aug 13, 2026 | 10-Q | 10-Q | ↗ |
| Aug 4, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jul 23, 2026 | 4 | 4 | ↗ |
| Jul 22, 2026 | D | Item 06b | ↗ |
| Jul 21, 2026 | 4 | 4 | ↗ |
| Jul 14, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Jul 14, 2026 | 8-K | Unregistered Sale of Securities; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Jul 14, 2026 | 4 | 4 | ↗ |
| Jul 14, 2026 | 4 | 4 | ↗ |
| Jul 14, 2026 | 4 | 4 | ↗ |
| Jul 14, 2026 | 4 | 4 | ↗ |
| Jul 2, 2026 | 4 | 4 | ↗ |
| Jun 29, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jun 24, 2026 | 4 | 4 | ↗ |
| Jun 22, 2026 | 4 | 4 | ↗ |
| Jun 17, 2026 | 4 | 4 | ↗ |
| May 14, 2026 | 10-Q | 10-Q | ↗ |
| May 5, 2026 | 8-K | Entry into a Material Agreement; Completion of Acquisition/Disposition; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Apr 16, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Apr 15, 2026 | 10-K | 10-K | ↗ |
| Apr 2, 2026 | 8-K | Entry into a Material Agreement; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 31, 2026 | NT 10-K | NT 10-K | ↗ |
| Mar 30, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Mar 30, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Jan 29, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jan 26, 2026 | 4 | 4 | ↗ |
| Jan 26, 2026 | 8-K | Entry into a Material Agreement; Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Jan 7, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Jan 6, 2026 | 8-K | Entry into a Material Agreement; Material Direct Financial Obligation; Financial Statements and Exhibits | ↗ |
| Jan 6, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Dec 30, 2025 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Dec 23, 2025 | EFFECT | Item ; Item ; Item | ↗ |
| Dec 23, 2025 | 424B3 | 424B3 | ↗ |
| Dec 23, 2025 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Dec 22, 2025 | CORRESP | ↗ | |
| Dec 22, 2025 | S-1/A | S-1/A | ↗ |
| Dec 11, 2025 | D | Item 06b | ↗ |
| Dec 9, 2025 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Financial Statements and Exhibits | ↗ |
| Nov 21, 2025 | S-1 | S-1 | ↗ |